Setting up the first children's laboratory in Slovenia in collaboration with Pionirski dom

  • The Children's Lab at the Pionirski dom Centre for Youth Culture in Ljubljana will offer a safe and stimulating environment for children aged 4 to 12 to explore and learn.
  • The lab will give children the chance to learn more about science, biochemistry, physics, technology, engineering and mathematics.
  • Talent management is one of Lek's priorities, as the company believes that an interest in science should be recognized and encouraged from an early age.
31. 5. 2024

Lek remains committed to supporting education and scientific research. They believe that science should be accessible to everyone, so they strive to bring science closer to young children through various activities and support for projects such as the Children's Lab at Pionirski dom.

The Children's Lab will give children aged 4 to 12 the opportunity to learn more about science, biochemistry, physics, technology, engineering and mathematics. The laboratory is equipped with professional equipment, microscopes, compounds, reagents, an interactive 3D periodic table and a library of scientific literature designed for children.

Robert Ljoljo, President of the Lek Board of Management and Sandoz Country President Slovenia, emphasized at the opening event that we need to spark an interest in science in young people as early as possible. "We are building the foundations for a future full of curiosity, innovation and scientific breakthroughs. When children explore and discover the world of science in a fun and interactive way, they develop their cognitive skills, critical thinking ability and creativity. At Lek, we support young talent at all levels of education because we believe that fostering curiosity and a love of science are key to the development and progress of our society." At the opening ceremony, Lek’s associates performed experiments and guided children through various scientific procedures, introducing them to the magical world of science in an accessible and engaging way.

Talent management is one of Lek's priorities and the company believes that an interest in science should be recognized and encouraged from an early age. They support the development of critical thinking and innovation through various activities at all levels of the education system, thus contributing to the creation of a more knowledge-based society.

* * *

About Lek
Lek, a Sandoz company, is the first and oldest pharmaceutical company in Slovenia, developing, manufacturing and marketing effective, safe and high-quality generics and biosimilars for patients around the world. Our work is guided by strong ethical standards, innovative thinking and the breakthrough achievements of our world-class professionals. With more than 3,700 associates, we have been actively shaping the Slovenian, European and global research and development landscape for decades. We are building a culture of open dialog, and we proudly and responsibly hold the title of most reputable employer in Slovenia.

About Sandoz
Sandoz (SIX: SDZ; OTCQX: SDZNY) is the global leader in generic and biosimilar medicines, with a growth strategy driven by its Purpose: pioneering access for patients. More than 20,000 people of 100 nationalities work together to ensure 800 million patient treatments are provided by Sandoz, generating substantial global healthcare savings and an even larger social impact. Its leading portfolio of approximately 1500 products addresses diseases from the common cold to cancer. Headquartered in Basel, Switzerland, Sandoz traces its heritage back to 1886. Its history of breakthroughs includes Calcium Sandoz in 1929, the world’s first oral penicillin in 1951, and the first biosimilar in 2006. In 2023, Sandoz recorded sales of USD 9.6 billion.

* * *

This Media Release contains forward-looking statements which offer no guarantee  with regard to future performance. These statements are made on the basis of  management’s views and assumptions regarding future events and business  performance at the time the statements are made. They are subject to risks and uncertainties including, but not confined to, future global economic  conditions, exchange rates, legal provisions, market conditions, activities by  competitors and other factors outside of the control of Sandoz. Should one or  more of these risks or uncertainties materialize or should underlying  assumptions prove incorrect, actual outcomes may vary materially from those  forecasted or expected. Each forward-looking statement speaks only as of the  date of the particular statement, and Sandoz undertakes no obligation to  publicly update or revise any forward-looking statements, except as required by  law.

- end -